TRINOR GLASS

as a leading enterprise in the pharmaceutical glass industry, has implemented its sustainable development strategy mainly in the following aspects

sustainability-banner3.webp
sustainability-banner2.webp

Innovation Driven

TRINOR focuses on technological innovation, committed to the research and development and production of USP TYPE I borosilicate glass, breaking the foreign technical monopoly, and achieving domestic substitution. The Cold-top All-electric Melting Vello Process technology used by the company not only improves product quality but also has significant environmental protection and cost-effective advantages.

Capacity Expansion

Through financing and project construction, TRINOR continuously expands its production scale, planning to add 30,000 tons of neutral borosilicate glass tube production capacity and 3 billion USP TYPE I borosilicate glass bottle production capacity to meet the demand of domestic and foreign markets.

Environmental Production

TRINOR pays attention to environmental protection in the production process, adopting the All-electric Melting Vello Process technology that does not produce wastewater or exhaust gas emissions, and has a high thermal energy utilization rate, achieving energy-saving and environment-friendly production.

sustainability-banner4.webp

Quality Control

The company's products have physical and chemical properties that reach the world-class level, some of the physical and chemical properties are at the world's leading level, and the glass formula does not contain arsenic, ensuring the safety and reliability of the products.

sustainability-banner6.webp

Market Expansion

TRINOR products not only occupy an important position in the domestic market but also sell overseas to over 40 countries and regions, completing the FDA-DMF master file in the United States, obtaining the international market recognition.

As the first company in China to be able to produce neutral borosilicate glass on a large scale, TRINOR has played a leading role in the industry, promoting the upgrade of the entire pharmaceutical packaging material industry.

Industry Leadership

sustainability-banner7.webp
sustainability-banner9.webp
sustainability-banner8.webp

Social Responsibility

During the pandemic, TRINOR adhered to "no suspension of work, no price increase," ensuring the packaging supply of anti-epidemic drugs, reflecting the company's social responsibility and commitment.

Policy Support

The investment and support from the state to TRINOR, such as the investment and project initiation by the National Development and Reform Commission, provide strong policy support for the company's sustainable development.

WhatsApp